Protagonist Therapeutics, Inc - Common Stock (PTGX)
CUSIP: 74366E102
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 62,457,444
- Total 13F shares
- 63,271,382
- Share change
- +1,639,248
- Total reported value
- $2,442,272,169
- Put/Call ratio
- 97%
- Price per share
- $38.60
- Number of holders
- 240
- Value change
- +$44,242,054
- Number of buys
- 130
- Number of sells
- 113
Quarterly Holders Quick Answers
What is CUSIP 74366E102?
CUSIP 74366E102 identifies PTGX - Protagonist Therapeutics, Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74366E102:
Top shareholders of PTGX - Protagonist Therapeutics, Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
|
Company |
16%
|
10,224,295
|
$460,093,275 | — | 30 Sep 2024 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
9.4%
|
5,861,006
|
$263,745,270 | — | 30 Sep 2024 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
8.7%
|
5,426,112
|
$244,175,040 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.8%
|
4,216,081
|
$189,723,645 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
5.1%
|
3,183,542
|
$143,259,390 | — | 30 Sep 2024 | |
| JOHNSON & JOHNSON |
13F
|
Company |
3.9%
|
2,449,183
|
$110,213,235 | — | 30 Sep 2024 | |
| BVF INC/IL |
13F
|
Company |
3%
|
1,850,167
|
$83,257,515 | — | 30 Sep 2024 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
2.9%
|
1,814,696
|
$81,661,320 | — | 30 Sep 2024 | |
| Pacer Advisors, Inc. |
13F
|
Company |
2.8%
|
1,734,090
|
$78,034,050 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
1,374,697
|
$61,872,974 | — | 30 Sep 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
2.2%
|
1,374,563
|
$61,855,335 | — | 30 Sep 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.1%
|
1,309,467
|
$58,927,000 | — | 30 Sep 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.9%
|
1,200,891
|
$54,040,095 | — | 30 Sep 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
1.6%
|
981,295
|
$44,158,275 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.3%
|
821,856
|
$36,983,520 | — | 30 Sep 2024 | |
| Invesco Ltd. |
13F
|
Company |
1%
|
653,152
|
$29,391,840 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1%
|
628,623
|
$28,288,075 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.93%
|
580,089
|
$26,104,005 | — | 30 Sep 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.92%
|
574,775
|
$25,864,875 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.91%
|
565,503
|
$25,447,635 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.81%
|
502,985
|
$22,634,325 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.75%
|
466,518
|
$20,993,310 | — | 30 Sep 2024 | |
| Kynam Capital Management, LP |
13F
|
Company |
0.73%
|
456,369
|
$20,536,605 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
0.73%
|
454,196
|
$20,438,820 | — | 30 Sep 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.71%
|
445,352
|
$20,040,840 | — | 30 Sep 2024 | |
| Eversept Partners, LP |
13F
|
Company |
0.71%
|
445,204
|
$20,034,180 | — | 30 Sep 2024 | |
| MANGROVE PARTNERS IM, LLC |
13F
|
Company |
0.7%
|
439,314
|
$19,769,130 | — | 30 Sep 2024 | |
| Focus Partners Wealth |
13F
|
Company |
0.68%
|
426,661
|
$19,199,745 | — | 30 Sep 2024 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.67%
|
420,000
|
$18,900,000 | — | 30 Sep 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.59%
|
368,132
|
$16,565,940 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.57%
|
356,333
|
$16,035,003 | — | 30 Sep 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.56%
|
350,000
|
$15,750,000 | — | 30 Sep 2024 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
0.55%
|
340,974
|
$15,343,830 | — | 30 Sep 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.52%
|
322,989
|
$14,534,505 | — | 30 Sep 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.51%
|
320,832
|
$14,437,440 | — | 30 Sep 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.5%
|
315,373
|
$14,191,785 | — | 30 Sep 2024 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.47%
|
294,280
|
$13,604,564 | — | 30 Sep 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.43%
|
267,033
|
$12,016,485 | — | 30 Sep 2024 | |
| Checkpoint Capital L.P. |
13F
|
Company |
0.38%
|
240,000
|
$10,800,000 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.37%
|
232,074
|
$10,443,330 | — | 30 Sep 2024 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.37%
|
230,114
|
$10,355,130 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.36%
|
225,589
|
$10,151,505 | — | 30 Sep 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.34%
|
214,872
|
$9,669,240 | — | 30 Sep 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.28%
|
172,202
|
$7,673,321 | — | 30 Sep 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.26%
|
164,178
|
$7,388,010 | — | 30 Sep 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.26%
|
162,492
|
$7,311,812 | — | 30 Sep 2024 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.25%
|
158,067
|
$7,113,015 | — | 30 Sep 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.24%
|
153,006
|
$6,885,271 | — | 30 Sep 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.23%
|
146,657
|
$6,599,565 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.23%
|
144,167
|
$6,487,515 | — | 30 Sep 2024 |
Institutional Holders of Protagonist Therapeutics, Inc - Common Stock (PTGX) as of Q4 2024
As of 31 Dec 2024,
Protagonist Therapeutics, Inc - Common Stock (PTGX) was held by
240 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,271,382 shares.
The largest 10 holders included
BlackRock, Inc., FARALLON CAPITAL MANAGEMENT LLC, RTW INVESTMENTS, LP, VANGUARD GROUP INC, STATE STREET CORP, JOHNSON & JOHNSON, BVF INC/IL, Pacer Advisors, Inc., Jefferies Financial Group Inc., and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
241
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
238
Q4 2024 holders
240
Holder diff
2
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.